Printer FriendlyPrintable version     Email this pageEmail this page
 
Search
 
 
  Advanced Search
 
Partnering
  Partnering Home
  Tech Transfer Offices
  Licensing Information
  Available Technologies
  Technologies by Subject
  Partnering Opportunities
  Agreements (CRADAs)
  Generic Forms
  Technology Successes
  Featured Item
  Legislative Affairs
  Vendors
 
 
  Display category headings
Partnering
Partnering >
Method to Produce Granulocyte Colony Stimulating Factor from Immortalized Avian T-Lymphocytes and Method to Produce Immortilized Cells
See also: US Patent Office Full Record

Patent Number: 5691200
Docket Number: 16895
Serial Number: 8675749
Date Patented: 11/25/1997

Agency:

Agricultural Research Service
Issued:
November 25, 1997

Abstract:
The invention involves a method to control a variety of pathogenic organisms such as Salmonella in poultry. The invention produces immortalized poultry T-cell lines which secrete lymphokines that enhance immunity. These cell lines may be produced from T cells recovered from fowl which have been hyperimmunized in vivo. These activated T cells are first exposed in vitro to a mitogen effective for secondary stimulation, and then virally transformed to produce an immortal cell line. When cultured in vitro, the cell lines produce and secrete immune lymphokines which may be administered by injection to poultry to increase resistance to infections.

Inventors:
Michael H. Kogut Rita B. Moyes
Food Animal Protection Research Lab (Same address as above)
College Station, Texas 77845 (409) 260-9374
(409) 260-9221/(409) 260-9332 (fax)
Larry H. Stanker Billy M. Hargis
(Same address as above) (Same address as above)
(409) 260-9306 (409) 845-8989/(409) 845-9972 (fax)
John R. DeLoach (former ARS)

Industry Keywords:

cell lines, hybridomas, monoclonal antibodies, pharmaceutical, enzymes, proteins, vaccine, biotechnology, animal health, veterinary, poultry

 
ARS Home |  USDA |  Home | About Us | Research | Products & Services | People & Places  | News & Events | Partnering | Careers | Contact Us | Help |
Site Map |  Freedom of Information Act |  Statements & Disclaimers |  Employee Resources |  FirstGov |  White House